We propose to use a mouse model of allergen induced airway remodeling to investigate the contribution ofmast cells to airway remodeling, as well as to understand the mechanism by which mast cell progenitorstraffic from the bone marrow to the lung and contribute to airway remodeling. In particular we hypothesizethat mast cell derived TNF plays a central role in mediating allergen induced airway remodeling througheffects on airway smooth muscle, as well as through recruitment of mast cell progenitors and eosinophils tothe lung. To test this hypothesis we plan to determine levels of allergen induced airway remodeling in WTmice and compare this to levels noted in mutant mice (mast cell deficient, TNF deficient), as well as mastcell deficient mice reconstituted with TNF deficient mast cells. In addition, we have utilized cre/lox moleculartechniques to generate mice deficient in the ability to activate NF-kB in airway epithelium. As these mutantmice exhibit reduced numbers of peribronchial mast cells, they will be utilized to investigate the role of NFkBregulated genes in airway epithelium contributing to mast cell progenitor trafficking to the remodeledairway. Overall, these studies will provide insight into the mechanism by which mast cell derived TNFcontributes to airway remodeling, as well improve our understanding of the mechanism by which NF-kBregulated genes in airway epithelium direct mast cell progenitor trafficking from the bone marrow to the lungand contribute to airway remodeling.TNF is a protein that is highly expressed in the airway in asthmatics with ongoing symptoms of asthma. Ourstudies in a mouse model will shed light on whether therapies targeting TN in asthma may provide a novelstrategy to reduce airway scarring in severe asthmatics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI070535-01
Application #
7150793
Study Section
Special Emphasis Panel (ZAI1-SV-I (M1))
Project Start
2006-07-01
Project End
2011-08-31
Budget Start
2006-07-01
Budget End
2007-08-31
Support Year
1
Fiscal Year
2006
Total Cost
$196,933
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Unno, Hirotoshi; Miller, Marina; Rosenthal, Peter et al. (2018) Activating transcription factor 6? (ATF6?) regulates airway hyperreactivity, smooth muscle proliferation, and contractility. J Allergy Clin Immunol 141:439-442.e4
Miller, Marina; Vuong, Christine; Garcia, Meghan Farrell et al. (2018) Does reduced zona pellucida binding protein 2 (ZPBP2) expression on chromosome 17q21 protect against asthma? J Allergy Clin Immunol 142:706-709.e4
Ordovas-Montanes, Jose; Dwyer, Daniel F; Nyquist, Sarah K et al. (2018) Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560:649-654
Herro, Rana; Shui, Jr-Wen; Zahner, Sonja et al. (2018) LIGHT-HVEM signaling in keratinocytes controls development of dermatitis. J Exp Med 215:415-422
Chen, Jun; Miller, Marina; Unno, Hirotoshi et al. (2018) Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca2+ oscillations in asthma. J Allergy Clin Immunol 142:207-218.e6
White, Andrew A; Doherty, Taylor A (2018) Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis. Am J Rhinol Allergy 32:7-11
Mehta, Amit K; Gracias, Donald T; Croft, Michael (2018) TNF activity and T cells. Cytokine 101:14-18
Karta, Maya R; Rosenthal, Peter S; Beppu, Andrew et al. (2018) ?2 integrins rather than ?1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung. J Allergy Clin Immunol 141:329-338.e12
Mehta, A K; Doherty, T; Broide, D et al. (2018) Tumor necrosis factor family member LIGHT acts with IL-1? and TGF-? to promote airway remodeling during rhinovirus infection. Allergy 73:1415-1424
Doherty, Taylor A; Broide, David H (2018) Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines. J Allergy Clin Immunol 141:1587-1589

Showing the most recent 10 out of 106 publications